A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies

Haemophilia

Volumn 16, Issue 4, 2010, Pages 569-583

  Todd, T ^a   Perry, D J ^b  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Prophylaxis; Rare inherited coagulation factor deficiencies

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DANAZOL; FIBRINOGEN; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; VITAMIN K GROUP;

AFIBRINOGENEMIA; ANAPHYLAXIS; BLEEDING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; BRAIN HEMORRHAGE; CRYOPRECIPITATE; DRUG DOSE REDUCTION; HEADACHE; HUMAN; LIVER DYSFUNCTION; LONG TERM CARE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN DEFICIENCY; REVIEW; URTICARIA; VITAMIN K DEPENDENT BLOOD CLOTTING FACTOR DEFICIENCY; VITAMIN K DEPENDENT CLOTTING FACTOR DEFICIENCY; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; FIBRINOGEN; HUMANS; VITAMIN K DEFICIENCY;

EID: 77954844714     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02118.x     Document Type: Review

References (123)

1. Guyatt G, Gutterman D, Baumann MH. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American college of chest physicians task force. Chest 2006, 129:174-81.
2. Grech H, Majumdar G, Lawrie AS, Savidge GF. Pregnancy in congenital afibrinogenaemia: report of a successful case and review of the literature. Br J Haematol 1991, 78:571-2.
3. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999, 107:204-6.
4. Goodwin TM. Congenital hypofibrinogenemia in pregnancy. Obstet Gynecol Surv 1989, 44:157-61.
5. Wyatt J, Brennan SO, May S, George PM. Hypofibrinogenaemia with compound heterozygosity for two γ chain mutations γ Ala→Gly and an intron two Gt→At splice site mutation. Thromb Haemost 2000, 84:449-52.
6. Acharya SS, Coughlin A, Dimichele DM. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004, 2:248-56.
7. Davis RL, Mosesson MW, Kerlin BA, Canner JA, Ruymann FB, Brennan SO. Fibrinogen Columbus: a novel gamma Gly200Val mutation causing hypofibrinogenemia in a family with associated thrombophilia. Haematologica 2007, 92:1151-2.
8. Monaldini L, Asselta R, Duga S. Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bb-chain gene. Haematologica 2006, 91:628-33.
9. Patiroglu T, Karakukcu M. Middle cerebral arterial thrombosis in a patient with hypofibrinogenemia, 5 days after rFVIIa and FFP infusion. Clin Appl Thromb Hemost 2006, 12:111-3.
10. al-Fawaz IM, Gader AM. Severe congenital dysfibrinogenemia (fibrinogen-Riyadh): a family study. Acta Haematol 1992, 88:194-7.
11. Hanss M, Biot F. A database for human fibrinogen variants. Ann NY Acad Sci 2001, 936:89-90. http://www.geht.org/databaseang/fibrinogen
12. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995, 73:151-61.
13. Parameswaran R, Dickinson JP, De Lord S, Keeling DM, Colvin BT. Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy. Haemophilia 2000, 6:705-8.
14. Fried K, Kaufman S. Congenital afibrinogenemia in 10 offsprings of uncle-niece marriage. Clin Genet 1980, 17:223-7.
15. Roque H, Stephenson C, Lee MJ. Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies. Am J Hematol 2004, 76:267-70.
16. Aygoren-Pursun E, Martinez Saguer I, Rusicke E. Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions. Am J Haematol 2007, 82:317-20.
17. Rodriguez RC, Buchanan GR, Clanton MS. Prophylactic cryoprecipitate in congenital afibrinogenemia. Clin Pediatr (Philia) 1998, 27:543-5.
18. Kreuz W, Meili E, Peter-Salonen K. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Trans Apher Sci 2005, 32:247-53.
19. Girolami A, Scarano L, Saggiorato G, Girolami B, Bertomoro A, Marchiori A. Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis 1998, 9:557-69.
20. Strijks E, Poort SR, Renier WO, Gabreels FJ, Bertina RM. Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy. Neuropediatrics 1999, 30:320-4.
21. Wong AYK, Hewitt J, Clarke BJ. Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion. J Thromb Haemost 2006, 4:2623-8.
22. Poort SR, Michiels JJ, Reitsma PH, Bertina RM. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 1994, 72:819-24.
23. Lefkowitz JB, Haver T, Clarke S, Jacobson L, Weller A, Nuss R. The prothrombin Denver patient has two different prothrombin point mutations resulting in Glu-300→Lys and Glu-309→Lys substitutions. Br J Haematol 2000, 108:182-7.
24. Montgomery RR, Otsuka A, Hathaway WE. Hypoprothrombinemia: case report. Blood 1978, 51:299-306.
25. Lobel JS, Majumdar S, Kovats-Bell S. Successful prophylactic treatment for bleeding in a girl with severe hereditary prothrombin deficiency using a prothrombin complex concentrate (Bebulin® VH). J Pediatr Hematol Oncol 2004, 26:480-3.
26. Owen CA, Henriksen RA, McDuffie FC, Mann KG. Prothrombin quick. A newly identified dysprothrombinaemia. Mayo Clin Proc 1978, 53:29-33.
27. Brenner B, Tavori S, Zivelin A. Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants. Br J Haematol 1990, 222:537-42.
28. Bhattacharyya J, Dutta P, Mishra P. Congenital vitamin K-dependent coagulation factor deficiency: a case report. Blood Coagul Fibrinolysis 2005, 16:525-7.
29. Oldenburg J, von Brederlow B, Fregin A. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000, 84:937-41.
30. McMahon MJ, James AH. Combined deficiency of factors II, VII, IX and X (Borgshulte-Grigsby Deficiency) in pregnancy. Obstet gynaecol 2001, 97:808-9.
31. Brenner B, Sánchez-Vega B, Wu SM, Lanir N, Stafford DW, Solera J. A missense mutation in γ-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 1998, 92:4554-9.
32. McMillan CW, Roberts HR. Congenital combined deficiency of coagulation factors II, VII, IX and X: report of a case. N Engl J Med 1966, 274:1313-5.
33. Lechler E. Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, Protein C, Protein S, or protein Z. Thromb Res 1999, 95:S39-50.
34. Lee WS, Chong LA, Begum S, Abdullah WA, Koh MT, Lim EJ. Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency. J Pediatr Hematol Oncol 2001, 23:244-6.
35. Salooja N, Martin P, Khair K, Liesner R, Hann I. Severe factor V deficiency and neonatal intracranial haemorrhage: a case report. Haemophilia 2000, 6:44-6.
36. Totan M, Albayrak D. Intracranial haemorrhage due to factor V deficiency. Acta Paediatr 1999, 88:342-3.
37. Whitelaw A, Haines ME, Bolsover W, Harris E. Factor V deficiency and antenatal intraventricular haemorrhage. Arch Dis Child 1984, 59:997-9.
38. Wadia RS, Sangle SA, Kripalaney S, Bafna M, Karva SR. Familial intracranial haemorrhage due to factor V deficiency. J Neurol Neurosurg Psychiatry 1992, 55:227-8.
39. Gonzalez-Boullosa R, Ocampo-Martinez R, Alarcon-Martin MJ, Suarez-Rodriguez M, Dominguez-Viguera L, Gonzalez-Fajo G. The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency. Haemophilia 2005, 11:167-70.
40. Borel-Derlon A, Slaoui M, Le Querrec A, Hugel B, Vos HL. Severe congenital factor V deficiency: successful treatment with recombinant factor VIIa in two brothers. Blood 2002, 100. abstract no. 3876
41. Divanon F, Hecquard C, Borel-Derlon A. Experience with use of recombinant activated factor VII. J Clin Pharm Ther 2002, 27:133-8.
42. Seligsohn U, Zivelin A, Zwang E. Combined factor V and factor VIII deficiency among non-Ashkenazi Jews. N Engl J Med 1982, 307:1191-5.
43. Peyvandi F, Tuddenham EGD, Akhtari AM, Lak M, Mannucci PM. Bleeding symptoms in Iranian patients with the combined deficiency of factor V and factor VIII. Br J Haematol 1998, 100:773-6.
44. Faioni EM, Fontana G, Carpani G. Review of clinical, biochemical and genetic aspects of combined factor V and factor VIII deficiency, and report of a new affected family. Thromb Res 2003, 112:269-71.
45. Ueno H, Asami M, Yoneda R. Management of cesarean section under replacement therapy with factor VIII concentrates in a pregnant case with congenital combined deficiency of factor V and factor VIII. Rinsho Ketsueki 1991, 32:981-5.
46. Chuansumrit A, Mahaphan W, Pintadit P. Combined factor V and factor VIII deficiency with congenital heart disease: response to plasma and DDAVP infusion. Southeast Asian J Trop Med Public Health 1994, 25:217-20.
47. Bauduer F, Guichandut JP, Ducout L. Successful use of fresh frozen plasma and desmopressin for transurethral prostatectomy in a french basque with combined factors V + VIII deficiency. J Thromb Haemost 2004, 2:675-6.
48. Giansily-Blaizot M, Aguilar-Martinez P, Briquel ME. Two novel cases of cerebral haemorrhages at the neonatal period associated with inherited factor VII deficiency, one of them revealing a new nonsense mutation (Ser52Stop). Blood Coagul Fibrinolysis 2003, 14:217-20.
49. Acharya SS, Coughlin A, Dimichele DM. Rare bleeding disorder tegistry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004, 2:248-56.
50. Peyvandi F, Mannucci PM, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia 1997, 3:242-6.
51. Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006, 12:413-6.
52. Hassan HJ, Casalbore P, De Laurenzi A, Petti N, Sinibaldi L, Orlando M. Hereditary factor VII deficiency: report of a case of intracranial hemorrhage. Haemostasis 1984, 14:244-8.
53. Ragni MV, Lewis JH, Spero JA, Hasiba U. Factor VII deficiency. Am J Hematol 1981, 10:79-88.
54. Kulkarni A, Lee CA, Griffeon A, Kadir RA. Disorders of menstruation and their effect on the quality of life in women with congenital factor VII deficiency. Haemophilia 2006, 12:248-52.
55. Herrmann FH, Wulff K, Auerswald G. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia 2009, 15:267-80.
56. Giansily-Blaizot M, Schved JF. Potential predictors of bleeding risk in inherited factor VII deficiency clinical, biological and molecular criteria. Thromb Haemost 2005, 94:901-6.
57. Chuansumrit A, Visanuyothin N, Puapunwattana S. Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency. J Med Assoc Thai 2002, 85(Suppl 4):S1059-64.
58. Mariani G, Dolce A, Marchetti G, Bernardi F. Clinical picture and management of congenital factor VII deficiency. Haemophilia 2004, 10(Suppl. 4):180-3.
59. Bauer KA. Treatment of factor VII deficiency with recombinant factor VIIa. Haemostasis 1996, 26:155-8.
60. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 2004, 78:1812-4.
61. Karimi M. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath. Semin Hematol 2008, 45(2 Suppl 1):S74.
62. Kankirawatana S, Mahasandana C, Veerakul G. Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency. Southeast Asian J Trop Med Public Health 2000, 31:795-800.
63. Huth-Kühne A, Rott H, Zimmermann R, Halimeh S. Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency. Thromb Haemost 2007, 10:912-5.
64. Farah RA, Hamod D, Melick N, Giansily-Blaizot M, Sallah S. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency. J Thromb Haemost 2007, 5:433-4.
65. Brummel Ziedins K, Rivard GE, Pouliot RL. Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2004, 2:1735-44.
66. Hennewig U, Eisert S, Wulff K, Herrmann FH, Schneider DT, Göbel U. Long-term FVII substitution in a preterm infant with severe gastrointestinal bleeding and FVII deficiency due to a homozygous donor splice mutation IVS4 + 1G→A. Pediatr Hematol Oncol 2006, 23:129-33.
67. Mathijssen NC, Masereeuw R, Verbeek K, Lavergne JM, Costa JM, van Heerde WL. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients. Br J Haematol 2004, 125:494-9.
68. Tcheng WY, Donkin J, Konzal S, Wong WY. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency. Haemophilia 2004, 10:295-8.
69. Cohen LJ, McWilliams NB, Neuberg R. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports. Am J Hematol 1995, 50:269-76.
70. Michaels LA, Philipp CS, Eisele J, Pappas H, Saidi P. Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII. Pediatr Blood Cancer 2007, 49:736-9.
71. Jimenez-Yuste V, Villar A, Morado M. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia 2000, 6:588-90.
72. Muleo G, Santoro R, Iannaccaro PG, Papaleo P, Leo F. The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies. Blood Coagul Fibrinol 1998, 9:389-90.
73. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002, 8:308-21.
74. Knight RD, Barr CF, Alving BM. Replacement therapy for congenital factor X deficiency. Transfusion 1985, 25:78-80.
75. Peyvandi F, Mannucci PM, Lak M. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Brit J Haematol 1998, 102:626-8.
76. Herrmann FH, Auerswald G, Ruiz-Saez A. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor X gen. Haemophilia 2006, 12:479-89.
77. Sumer T, Ahmad M, Sumer NK, Al Mouzan MI. Severe congenital factor X deficiency with intracranial haemorrhage. Eur J Pediatr 1986, 145:119-20.
78. Mukhopadhyay S, Saxena R, Kashyap R, Choudhry VP. Danazol therapy in factor X deficiency. Haemophilia 2001, 7:504-6.
79. De Sousa C, Clark T, Bradshaw A. Antenatally diagnosed subdural haemorrhage in congenital factor X deficiency. Arch Dis Child 1988, 63:1168-74.
80. Kouides PA, Kulzer L. Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate. Haemophilia 2001, 7:220-3.
81. el Kalla S, Menon NS. Neonatal congenital Factor X deficiency. Pediatr Hematol Oncol 1991, 8:347-54.
82. Machin SJ, Winter MR, Davies SC, Mackie IJ. Factor X deficiency in the neonatal period. Arch Dis Child 1980, 55:406-8.
83. McMahon C, Smith J, Goonan C, Byrne M, Smith OP. The role of primary prophylactic factor replacement therapy in children with severe factor X deficiency. Br J Haematol 2002, 119:789-91.
84. Menon NS. Letter to the editor: Factor X deficiency: an unusual cause of spontaneous intracranial bleeding. Indian Pediatr 2000, 37:1390.
85. Ramdas J, Ode D, Warrier RP. Factor X deficiency: an unusual cause for spontaneous intracranial bleeding. Indian Pediatr 2000, 37:656-9.
86. Sandler E, Gross S. Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant. Am J Pediatr Hematol Oncol 1992, 14:163-5.
87. Todd T, Perry DJ, Hayman E, Lawrence K, Gattens M, Baglin T. Severe factor X deficiency due to a homozygous mutation Cys364Arg that disrupts a disulphide bond in the catalytic domain. Haemophilia 2006, 12:1-4.
88. Shpilberg O, Peretz H, Zivelin A. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995, 85:429-32.
89. Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, Slack J, Kernoff PB. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988, 69:521-8.
90. Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS. Thrombogenic potential of factor XI concentrate. Lancet 1994, 344:748-9.
91. Mannucci PM, Bauer KA, Santagostino E. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 1994, 84:1314-9.
92. O'Connell NM, Riddell AF, Pascoe G, Perry DJ, Lee CA. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency. Haemophilia 2008, 14:775-81.
93. Lawler P, White B, Pye S. Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia 2002, 8:145-8.
94. Castaman G, Ruggeri M, Rodeghiero F. Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency. Br J Haematol 1996, 94:168-70.
95. Miloszewski KA. Factor XIII deficiency. Br J Haematol 1999, 107:468-84.
96. Mannucci PM, Frederici AB. Antibodies to Von Willebrand factor in Von Willebrand Disease. Inhibitors to Coagulation Factors in the 1990s 1995, 87-92. Aledort LM, Hoyer LWReissner JMWhite GC. in, eds, New York, Plenum Press
97. Lak M, Peyvandi F, Sharifian AA, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003, 1:1852-3.
98. Behring CSL. http://www.cslbehring.co.uk/docs/1022/348/Fibrogammin%20P%20UK%20SmPC%2028-Feb-07.pdf, Available at: (last accessed 8 January 2009)
99. Briggs NJ, Harman CT, Gascoigne E. A decade of experience with a factor XIII concentrate. Thromb Haemost 1997, 77(Suppl):35-6.
100. Hilgartner MW, McDonagh J, Gootenberg JE. Experience with fibrogammin for the long term treatment of congenital factor XIII deficiency in the USA. Blood 1991, 78(Suppl 1):60a.
101. Gootenberg JE. Factor concentrates for the treatment of factor XIII deficiency. Curr Opin Hematol 1998, 5:372-5.
102. Board PG, Losowsky MS, Miloszewski KJ. Factor XIII: inherited and acquired deficiency. Blood Rev 1993, 7:229-42.
103. Dreyfus M, Arnuti B, Beurrier P. Safety and efficacy of fibrogammin P for the treatment of patients with severe FXIII deficiency. J Thromb Haemost 2003, 1(Suppl 1):P0299.
104. Nugent DJ. Prophylaxis in rare coagulation disorders - factor XIII deficiency. Thromb Res 2006, 118(Suppl 1):S23-8.
105. Anwar R, Minford A, Gallivan L, Trinh CH, Markham AF. Delayed umbilical bleeding - a presenting feature for factor XIII deficiency: clinical features, genetics and management. Pediatrics 2002, 109:e32-8.
106. Al-Sharkawy IA, Aboobacker KC, Bourhama MH. Factor XIII deficiency in a Kuwaiti child: typical presentation with delayed diagnosis. Kuwait Med J 2006, 38:147-8.
107. Lorand L, Urayama T, de Kiewet J, Nossel HL. Diagnostic and genetic studies on fibirin stabilising factor with a new assay based on amine incorporation. J Clin Invest 1969, 48:1054-64.
108. Henriksson P, McDonagh J, Villa M. type I autoimmune inhibitor of factor XIII in a patient with congenital factor XIII deficiency. Thromb Haemost 1983, 50:272.
109. Lak M, Peyvandi F, Mannucci M. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol 2000, 111:1236-9.
110. Fressinaud E, Meyer D. International survey of patients with von Willebrand disease and angiodysplasia. Thromb Haemost 1993, 70:546.
111. Siragusa S, Malato A, Lo Coco L. Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management. Haemophilia 2008, 14:150-2.
112. Mannucci PM, Chediak J, Hanna W. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 2002, 99:450-6.
113. Mannucci PM. Venous thromboembolism in von Willebrand disease. Thromb Haemost 2002, 88:378-9.
114. Makris M, Colvin B, Gupta V. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease. Thromb Haemost 2002, 88:387-8.
115. Coppola A, Cimino E, Conca P. Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding. Haemophilia 2006, 12:90-4.
116. Berntorp E, Petrini P. Long-term prophylaxis in von Willebrand disease. Blood Coagul Fibrinolysis 2005, 16(Suppl 1):S23-6.
117. Federici AB, Castaman G, Franchini M. Clinical use of Haemate®P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. Haematologica 2007, 92:944-51.
118. Berntorp E, Abshire T. For the von Willebrand disease prophylaxis network steering committee. The von Willebrand disease prophylaxis network: exploring a treatment concept. J Thromb Haemost 2006, 4:2511-2.
119. Federici AB, Gianniello F, Canciani MT, Mannucci PM. Secondary long-term prophylaxis in severe patients with von Willebrand's disease: an Italian cohort study. Blood 2005, 106.
120. Baronciani L, Cozzi G, Canciani MT. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 2003, 30:264-70.
121. Journeycake JM, Quinn CT, Miller KL. Catheter-related deep venous thrombosis in children with hemophilia. Blood 2001, 98:1727-31.
122. Mazzucconi MG, Solinas S, Chistolini A, Motta M, Mariani G. Inhibitor to factor V in severe factor V congenital deficiency. A case report. Nouv Rev Fr Hematol 1985, 27:303-5.
123. Fratantoni JC, Hilgartner M, Nachman RL. Nature of the defect in congenital factor V deficiency: study in a patient with an acquired circulating anticoagulant. Blood 1972, 39:751-8.